HHS Launches $134–$144 Million STOMP Program as EPA Draft List Flags Microplastics and Pharmaceuticals as Potential Drinking‑Water Contaminants
HHS Secretary Robert F. Kennedy Jr. announced STOMP, a $134–$144 million national program to study microplastics in the human body — prioritizing pregnant people, children and high‑exposure workers — to fund standardized measurement tools and pursue a clinically usable test within five years that would cost under $50 and take under 15 minutes. EPA Administrator Lee Zeldin unveiled draft Contaminant Candidate List 6, which for the first time adds microplastics and pharmaceuticals as contaminant groups, expands the CCL and issues non‑binding human‑health benchmarks for nearly 400 pharmaceuticals while opening a 60‑day public comment period ahead of a planned final decision by Nov. 17, 2026.
📌 Key Facts
- HHS launched STOMP (Systemic Targeting of MicroPlastics), a national research program funded at roughly $134–$144 million to study microplastics in the human body and develop methods to detect, quantify and remove them.
- STOMP will prioritize research on pregnant people, children and workers with high microplastics exposure and will fund standardized tools to measure microplastics in human tissues and fluids.
- ARPA‑H director Dr. Alicia Jackson said STOMP aims within five years to deliver a clinically usable microplastics test that takes under 15 minutes and costs under $50 so it can be broadly accessible.
- HHS Secretary Robert F. Kennedy Jr. and EPA Administrator Lee Zeldin announced the initiative at a press event, framing microplastics as an urgent, existing health threat; Kennedy cited claims of about a 50% increase in plastic concentrations in the human brain since 2016 and a clinical study linking microplastics in arterial plaque to a 450% higher three‑year risk of heart attack, stroke or death.
- EPA unveiled the draft Contaminant Candidate List 6 (CCL 6), which for the first time adds microplastics and pharmaceuticals as contaminant groups, opens a 60‑day public comment period, and targets a final signature by November 17, 2026.
- CCL 6 expands the list to 75 chemicals, nine microbes, and four chemical groups (PFAS, disinfection byproducts, pharmaceuticals and microplastics), removes cyanotoxins as a chemical group, and the EPA has released non‑binding human‑health benchmarks for roughly 374–400 pharmaceuticals in drinking water (including antibiotics, antidepressants and hormones).
- Public‑health experts, including Dr. Celine Gounder, cautioned that adding microplastics to the CCL is an early step and highlighted major gaps: lack of standardized measurement methods, limited national exposure data, and insufficient evidence linking typical exposure levels to specific health outcomes.
📊 Relevant Data
64% of US residents who face cancer risks from living near plastic factories are people of color, compared to the national population where people of color make up about 42% of the total population.
How Microplastics Harm Black People More — Blavity
Black people in the US are disproportionately exposed to microplastics and nanoplastics due to living closer to sources like burning plastic emissions, with Black Americans comprising 13.6% of the population but facing higher exposure rates.
How Microplastics Harm Black People More — Blavity
US coastal counties with high marine microplastic levels show an 18% higher adjusted prevalence of Type 2 diabetes, with demographic data indicating that coastal populations include higher proportions of racial minorities in some areas, such as Hispanic populations at 19% nationally but varying by county.
Living near an ocean polluted by microplastics may increase cardiometabolic disease risk — American Heart Association
Communities with lower socioeconomic status and higher proportions of racial minorities in the US experience higher exposures to drinking water contaminants, including PFAS which are grouped with pharmaceuticals in regulatory lists, with low-food-access neighborhoods showing elevated PFAS levels.
Study finds health disparities in PFAS levels linked to drinking water, food access and industrial pollution — USC Keck School of Medicine
In California, higher-income individuals consume more bottled water, which contains six times higher microplastic concentrations than tap water, leading to greater exposure; approximately 16% of surveyed consumers identified as Hispanic, compared to California's Hispanic population of about 40%.
Microplastic exposure disparities in California communities through bottled water consumption — Springer
📰 Source Timeline (3)
Follow how coverage of this story developed over time
- HHS Secretary Robert F. Kennedy Jr. and EPA Administrator Lee Zeldin personally announced the initiative at a Thursday press event and framed microplastics as an urgent, existing health threat rather than a distant risk.
- Kennedy cited new claims that plastic concentrations in the human brain have increased by about 50% since 2016, equating to roughly “a spoonful of plastic in every human brain,” and referenced a clinical study linking microplastics in arterial plaque to a 450% higher three‑year risk of heart attack, stroke or death.
- ARPA‑H director Dr. Alicia Jackson said STOMP aims within five years to deliver a clinically usable microplastics test that takes under 15 minutes and costs under $50 so it can be broadly accessible to Americans.
- EPA’s Lee Zeldin said CCL 6 places microplastics on the Contaminant Candidate List for the first time and announced non‑binding human‑health benchmarks for nearly 400 pharmaceuticals in drinking water, including antibiotics, antidepressants and hormones.
- HHS Secretary Robert F. Kennedy Jr. announced a $144 million national program called STOMP (Systemic Targeting of MicroPlastics) to study microplastics in the human body and develop methods to detect, quantify, and remove them.
- STOMP will prioritize research on pregnant people, children, and workers with high microplastics exposure, and will fund standardized tools for measuring microplastics in human tissues and fluids.
- EPA Administrator Lee Zeldin formally unveiled the draft Contaminant Candidate List 6, which for the first time adds both microplastics and pharmaceuticals as contaminant groups, outlines a 60‑day public comment period, and targets final signature by November 17, 2026.
- CCL 6 expands the list to 75 chemicals, nine microbes, and four chemical groups (PFAS, disinfection byproducts, pharmaceuticals, microplastics) while removing cyanotoxins as a chemical group, and the EPA has released human‑health benchmarks for 374 pharmaceuticals.
- Dr. Celine Gounder emphasized that adding microplastics to the CCL is only an early step and highlighted gaps: lack of standardized measurement methods, lack of national exposure data, and limited evidence linking typical exposure to specific health outcomes.